Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients

BACKGROUND: We previously reported improved pathologic complete response (pCR) in a prospective phase II study using neoadjuvant bevacizumab in combination with chemotherapy compared to chemotherapy alone in breast cancer patients (41% vs. 25%, p = 0.0291). In this study, we queried germline single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Makhoul, Issam, Todorova, Valentina K., Siegel, Eric R., Erickson, Stephen W., Dhakal, Ishwori, Raj, Vinay R., Lee, Jeannette Y., Orloff, Mohammed S., Griffin, Robert J., Henry-Tillman, Ronda S., Klimberg, Suzanne, Hutchins, Laura F., Kadlubar, Susan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207665/
https://www.ncbi.nlm.nih.gov/pubmed/28045923
http://dx.doi.org/10.1371/journal.pone.0168550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207665/
https://www.ncbi.nlm.nih.gov/pubmed/28045923
http://dx.doi.org/10.1371/journal.pone.0168550

Ejemplares similares